Cargando…
Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders
Patient Activation Measure-13 (PAM-13) is a valid and widely used questionnaire that assess an individual’s knowledge, confidence, and skills for self-management of their chronic illness. Although there is some evidence regarding its reliability, the test–retest reliability has not been investigated...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908201/ https://www.ncbi.nlm.nih.gov/pubmed/33572717 http://dx.doi.org/10.3390/ijerph18031185 |
_version_ | 1783655658072047616 |
---|---|
author | Melby, Katrine Nygård, Mona Brobakken, Mathias Forsberg Gråwe, Rolf W. Güzey, Ismail Cüneyt Reitan, Solveig Klæbo Vedul-Kjelsås, Einar Heggelund, Jørn Tchounwou, Paul B. |
author_facet | Melby, Katrine Nygård, Mona Brobakken, Mathias Forsberg Gråwe, Rolf W. Güzey, Ismail Cüneyt Reitan, Solveig Klæbo Vedul-Kjelsås, Einar Heggelund, Jørn Tchounwou, Paul B. |
author_sort | Melby, Katrine |
collection | PubMed |
description | Patient Activation Measure-13 (PAM-13) is a valid and widely used questionnaire that assess an individual’s knowledge, confidence, and skills for self-management of their chronic illness. Although there is some evidence regarding its reliability, the test–retest reliability has not been investigated among patients with substance use disorders (SUDs) or schizophrenia spectrum disorders. We investigated the internal consistency and test–retest reliability of PAM-13 in these populations. Test–retest reliability was analysed using data from 29 patients with SUDs and 28 with schizophrenia spectrum disorders. Cronbach’s α and Intraclass Correlation Coefficient (ICC) scores were used to examine internal consistency and test–retest reliability, respectively. Of the 60 collected test–retest questionnaires, 57 were included in the analyses. No mean differences between time one (T1) and time two (T2) were observed in either patient group, except for item 12 in schizophrenia spectrum disorders patients (p < 0.05). Internal consistency for T1 and T2 was 0.75 and 0.84 in SUDs patients and 0.87 and 0.81 in schizophrenia spectrum disorders patients, respectively. The ICC was r = 0.86 in patients with SUDs and r = 0.93 in patients with schizophrenia spectrum disorders. To conclude, PAM-13 showed good internal consistency and test–retest reliability in SUDs and schizophrenia spectrum disorders patients. |
format | Online Article Text |
id | pubmed-7908201 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79082012021-02-27 Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders Melby, Katrine Nygård, Mona Brobakken, Mathias Forsberg Gråwe, Rolf W. Güzey, Ismail Cüneyt Reitan, Solveig Klæbo Vedul-Kjelsås, Einar Heggelund, Jørn Tchounwou, Paul B. Int J Environ Res Public Health Brief Report Patient Activation Measure-13 (PAM-13) is a valid and widely used questionnaire that assess an individual’s knowledge, confidence, and skills for self-management of their chronic illness. Although there is some evidence regarding its reliability, the test–retest reliability has not been investigated among patients with substance use disorders (SUDs) or schizophrenia spectrum disorders. We investigated the internal consistency and test–retest reliability of PAM-13 in these populations. Test–retest reliability was analysed using data from 29 patients with SUDs and 28 with schizophrenia spectrum disorders. Cronbach’s α and Intraclass Correlation Coefficient (ICC) scores were used to examine internal consistency and test–retest reliability, respectively. Of the 60 collected test–retest questionnaires, 57 were included in the analyses. No mean differences between time one (T1) and time two (T2) were observed in either patient group, except for item 12 in schizophrenia spectrum disorders patients (p < 0.05). Internal consistency for T1 and T2 was 0.75 and 0.84 in SUDs patients and 0.87 and 0.81 in schizophrenia spectrum disorders patients, respectively. The ICC was r = 0.86 in patients with SUDs and r = 0.93 in patients with schizophrenia spectrum disorders. To conclude, PAM-13 showed good internal consistency and test–retest reliability in SUDs and schizophrenia spectrum disorders patients. MDPI 2021-01-29 2021-02 /pmc/articles/PMC7908201/ /pubmed/33572717 http://dx.doi.org/10.3390/ijerph18031185 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Melby, Katrine Nygård, Mona Brobakken, Mathias Forsberg Gråwe, Rolf W. Güzey, Ismail Cüneyt Reitan, Solveig Klæbo Vedul-Kjelsås, Einar Heggelund, Jørn Tchounwou, Paul B. Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders |
title | Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders |
title_full | Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders |
title_fullStr | Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders |
title_full_unstemmed | Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders |
title_short | Test-Retest Reliability of the Patient Activation Measure-13 in Adults with Substance Use Disorders and Schizophrenia Spectrum Disorders |
title_sort | test-retest reliability of the patient activation measure-13 in adults with substance use disorders and schizophrenia spectrum disorders |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908201/ https://www.ncbi.nlm.nih.gov/pubmed/33572717 http://dx.doi.org/10.3390/ijerph18031185 |
work_keys_str_mv | AT melbykatrine testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT nygardmona testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT brobakkenmathiasforsberg testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT grawerolfw testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT guzeyismailcuneyt testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT reitansolveigklæbo testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT vedulkjelsaseinar testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT heggelundjørn testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders AT tchounwoupaulb testretestreliabilityofthepatientactivationmeasure13inadultswithsubstanceusedisordersandschizophreniaspectrumdisorders |